Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

This study has been terminated.
(Difficulty identifying and enrolling eligible patients)
Information provided by (Responsible Party):
ZARS Pharma Inc. Identifier:
First received: January 16, 2006
Last updated: June 4, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2006
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)